skip to main content

News Archive

Date: 06/28/2018
U.S. News & World Report ranked C.S. Mott Children’s Hospital No. 1 in Michigan and 24th in the nation for pediatric cancer care in its 2018 rankings of best children’s hospitals.
Date: 06/26/2018
Many cancer patients use alternative medicine, including supplements, massage therapy, yoga, and acupuncture, while undergoing conventional cancer care. Such therapies are usually acceptable, but patients must discuss such therapies with their oncologist, because interactions may occur.
Date: 06/15/2018
Researchers at the U-M Rogel Cancer Center have discovered the process that allows immune suppressor cells to develop, suggesting a potential new way to bolster immunotherapy treatment.
Date: 06/07/2018
The University of Michigan Rogel Cancer Center has partnered with 69 other National Cancer Institute-designated cancer centers to issue a statement urging for increased HPV vaccination and screening to eliminate HPV-related cancers, starting with cervical cancer.
Date: 06/06/2018
A new study shows how to personalize the lung cancer screening decision for every patient. The results could help doctors fine-tune their advice to patients so that it’s based not only on a patient’s individual lung cancer risk and the potential benefits and harms of screening, but also the patient’s attitude about looking for problems and dealing with the consequences.
Date: 06/06/2018
Media contact: Jessica Webster-Sendra, 734-764-2220 |  Patients may contact Cancer AnswerLine, 800-865-1125
Date: 05/20/2018
Researchers from the University of Michigan Rogel Cancer Center will attend the American Society for Clinical Oncology (ASCO) Annual meeting from Friday, June 1 through Tuesday, June 5. Many of them plan to participate in poster sessions. A schedule is available to make it easy to know who is presenting, when, where and on what topic.
Date: 05/14/2018
Media Contact: Nicole Fawcett, 734-764-2220 | Patients may contact Cancer AnswerLine, 800-865-1125
Date: 05/09/2018
Although it is rare, knowledge of this risk is important both for the ophthalmologists who treat it and for the oncologists prescribing the anti-cancer treatment, say Michigan Medicine researchers. The cases of three recent patients, published in JAMA Ophthalmology, highlight the issue. Patients receiving immune checkpoint inhibitors developed uveal effusions and eye inflammation that affected their vision.
Date: 05/09/2018
Researchers from the University of Michigan Rogel Cancer Center will attend the American Society for Cancer Oncology (ASCO) Annual meeting from Friday, June 1 through Tuesday, June 5. Many of them plan to participate in poster sessions. A schedule is available to make it easy to know who is presenting, when, where and on what topic.

Pages